Skip to main content
Clinical Trials/IRCT201208261579N3
IRCT201208261579N3
Completed
Phase 2

Evaluating the Effects of Intranasal Injection of Botulinum Toxin-A Compared with Cetirizine on Symptoms of Rhinitis in Adult Patients with Allergic Rhinitis

Vice Chancellor for Research, Isfahan University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Allergic rhinitis.
Sponsor
Vice Chancellor for Research, Isfahan University of Medical Sciences
Enrollment
50
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for Research, Isfahan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • 1\- Adult patients with allergic rhinitis according to the Allergic Rhinitis and its Impact on Asthma criteria,
  • 2\- Having at least three symptoms of sneezing, nasal congestion, and rhinorrhea.
  • Exclusion criteria:
  • 1\- History of nasal anatomic abnormality,
  • 2\- Persistent asthma,
  • 3\- Long term use of systemic corticosteroids,
  • 4\- Malignancy, tuberculosis, diabetes mellitus, or other chronic systemic disease,
  • 5\- History of rhinoplasty,
  • 6\- Pregnant women,
  • 7\- Being on local corticosteroids at the time of enrollment.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials